Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
ACP Stock Summary
Top 10 Correlated ETFs
ACP
In the News

Weekly Closed-End Fund Roundup - March 5, 2023
19 out of 22 CEF sectors were positive on price and 12 out of 22 sectors were positive on NAV last week. Delaware/Abrdn mergers are closing this week.

IVH: Last 3 Days To Get A 6% Discount On ACP
IVH is set to be merged into ACP on March 10, 2023. Although it has narrowed, the two CEFs are still trading with a difference in discounts to net asset value.

Weekly Closed-End Fund Roundup: February 19, 2023
0 out of 22 closed-end fund sectors positive on price and 3 out of 22 sectors positive on NAV last week. KIO rights offering results.

CEF Merger Arbitrage: Sell ACP And Buy IVH
ACP is overvalued heading into its merger with IVH. Potentially make 10% in two weeks by selling ACP and buying IVH.

Weekly Closed-End Fund Roundup: February 12, 2023
1 out of 22 CEF sectors positive on price and 0 out of 22 sectors positive on NAV last week. Senior loans lead while real estate lags.

Weekly Closed-End Fund Roundup: DEX Tender Offering Expires (February 5, 2023)
17 out of 22 CEF sectors positive on price and 18 out of 22 sectors positive on NAV last week. RSF offering results.

ACP: Time To Take Some Profits On This 15% Yielding CEF
Aberdeen Income Credit Strategies Fund is a fixed income closed-end fund. ACP is up an astounding 27% since October.

Weekly Closed-End Fund Roundup: January 8, 2023
21 out of 22 CEF sectors were positive on price and 20 out of 22 sectors were positive on NAV last week. MLPs are the most discounted CEF sector.

Weekly Closed-End Fund Roundup: PIMCO Muni CEF Distribution Cuts (January 1, 2023)
3 out of 23 CEF sectors positive on price and 6 out of 23 sectors positive on NAV last week. PIMCO muni CEFs cut.

Weekly Closed-End Fund Roundup: VFL Tender Results (December 18, 2022)
2 out of 23 CEF sectors were positive on price and 2 out of 23 sectors were positive on NAV last week. VFL offers tender results.
ACP Financial details
ACP Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-10-31
Metric | History | 2018-10-31 | 2019-10-31 | 2020-10-31 | 2021-10-31 | 2022-10-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.35 | -0.12 | -0.17 | 1.54 | -2.54 | |
Net income per share | 0.27 | -0.18 | -0.2 | 1.5 | -2.57 | |
Operating cash flow per share | 1.37 | 1.48 | -1.26 | -4.74 | 2.08 | |
Free cash flow per share | 1.37 | 1.48 | -1.26 | -4.74 | 2.08 | |
Cash per share | 0 | 0 | 0.07 | 0 | 0 | |
Book value per share | 14.28 | 12.96 | 8.63 | 12.17 | 7.16 | |
Tangible book value per share | 14.28 | 12.96 | 8.63 | 12.17 | 7.16 | |
Share holders equity per share | 14.28 | 12.96 | 8.63 | 12.17 | 7.16 | |
Interest debt per share | 6.62 | 5.94 | 4.04 | 5.13 | 3.89 | |
Market cap | 168.75M | 142.4M | 188.22M | 262.39M | 148.18M | |
Enterprise value | 251.75M | 214.4M | 267.93M | 380.39M | 236.07M | |
P/E ratio | 48.48 | -62.94 | -45.9 | 7.5 | -2.48 | |
Price to sales ratio | 37.94 | -96.4 | -54.53 | 7.34 | -2.51 | |
POCF ratio | 9.55 | 7.64 | -7.31 | -2.38 | 3.06 | |
PFCF ratio | 9.55 | 7.64 | -7.31 | -2.38 | 3.06 | |
P/B Ratio | 0.92 | 0.87 | 1.06 | 0.93 | 0.89 | |
PTB ratio | 0.92 | 0.87 | 1.06 | 0.93 | 0.89 | |
EV to sales | 56.6 | -145.14 | -77.63 | 10.64 | -4 | |
Enterprise value over EBITDA | 42.89 | 483.49 | -109.44 | 10.47 | -4.13 | |
EV to operating cash flow | 14.25 | 11.51 | -10.41 | -3.45 | 4.88 | |
EV to free cash flow | 14.25 | 11.51 | -10.41 | -3.45 | 4.88 | |
Earnings yield | 0.02 | -0.02 | -0.02 | 0.13 | -0.4 | |
Free cash flow yield | 0.1 | 0.13 | -0.14 | -0.42 | 0.33 | |
Debt to equity | 0.46 | 0.49 | 0.49 | 0.45 | 0.8 | |
Debt to assets | 0.31 | 0.33 | 0.33 | 0.31 | 0.45 | |
Net debt to EBITDA | 14.14 | 162.36 | -32.56 | 3.25 | -1.54 | |
Current ratio | 0 | 0 | 0 | 0 | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 5.08 | -8.24 | 6.28 | -3.15 | -0.81 | |
Dividend Yield | 0.11 | 0.13 | 0.13 | 0.09 | 0.21 | |
Payout ratio | 5.41 | -8.32 | -5.82 | 0.69 | -0.52 | |
Sales general and administrative to revenue | 0.24 | -0.71 | -0.28 | 0.03 | -0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 9.31 | 7.25 | 6.23 | 20.29 | 20.34 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0.01 | -0.01 | -0.02 | 0.09 | -0.2 | |
Graham Net | -6.1 | -5.82 | -3.97 | -5.12 | -5.55 | |
Working capital | 0 | 0 | 0 | 0 | 0 | |
Tangible asset value | 184.03M | 162.94M | 176.87M | 283.08M | 166.65M | |
Net current asset value | -83.74M | -79.58M | -87.1M | -126.06M | -134.02M | |
Invested capital | 0.45 | 0.44 | 0.46 | 0.42 | 0.53 | |
Average receivables | 7.23M | 7.72M | 7.05M | 7.44M | 7.86M | |
Average payables | 1.73M | 1.94M | 4.52M | 6.11M | 5.47M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 562.38 | -2.12K | -583.02 | 95.54 | -39.34 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0.65 | -0.17 | -0.63 | 3.82 | -9.28 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0.02 | -0.01 | -0.02 | 0.12 | -0.36 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2022-04-30 for Q2
Metric | History | 2020-04-30 | 2020-10-31 | 2021-04-30 | 2021-10-31 | 2022-04-30 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 65.5M | 79.72M | 90M | 118M | 110M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.48 | 0.49 | 0.47 | 0.45 | 0.44 | |
Debt to assets | 0.33 | 0.33 | 0.32 | 0.31 | 0.31 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 0 | 0 | 0 | 0 | 0 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 0 | 0 | 0 | 0 | 0 | |
Tangible asset value | 147.82M | 176.87M | 202.74M | 283.08M | 252.25M | |
Net current asset value | -71.19M | -87.1M | -95.15M | -126.06M | -110.83M | |
Invested capital | 0.44 | 0.46 | 0.44 | 0.42 | 0.44 | |
Average receivables | 8.15M | 6.61M | 7.45M | 9.38M | 8.71M | |
Average payables | 3.64M | 4.5M | 4.99M | 5.73M | 3.51M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
ACP Frequently Asked Questions
What is Aberdeen Income Credit Strategies Fund stock symbol ?
Aberdeen Income Credit Strategies Fund is a GB stock and trading under the symbol ACP
What is Aberdeen Income Credit Strategies Fund stock quote today ?
Aberdeen Income Credit Strategies Fund stock price is $6.5 today.
Is Aberdeen Income Credit Strategies Fund stock public?
Yes, Aberdeen Income Credit Strategies Fund is a publicly traded company.